ClinicalTrials.Veeva

Menu

Risk Stratified Multidisciplinary Ambulatory Management of Malignant Bowel Obstruction in Gynecological Cancers (MAMBO)

University Health Network, Toronto logo

University Health Network, Toronto

Status

Completed

Conditions

Gynecologic Cancer

Treatments

Other: Management algorithm for Malignant Bowel Obstruction

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Management of Malignant Bowel Obstruction (MBO) in Patients with Advanced Gynecological Cancers

Full description

Guidelines for the management of patients with Malignant Bowel Obstruction(MBO) are not available and as such, there remains an urgent need for a collaborative approach to streamline patient care and optimize use of hospital resources. This study will focus on management of MBO in advanced gynecological cancers.If patients with MBO can be effectively managed in an ambulatory setting, this may improve quality and consistency of patient care, and help reduce volume and duration of bed occupancy.

Enrollment

96 patients

Sex

Female

Ages

18 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Histologically and /or cytologically confirmed gynecological cancer, including ovarian, fallopian tube, endometrial, cervical or primary peritoneal cancer Deemed to be at risk of developing or have a clinical diagnosis of MBO as defined using the following criteria: clinical evidence of bowel obstruction (history/physical/radiological examination; and bowel obstruction beyond the ligament of Treitz.

Exclusion criteria

There are no specified exclusion criteria for this study

Trial contacts and locations

1

Loading...

Central trial contact

Ruth Carey; Stephanie L'heureux

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems